348 filings
Page 2 of 18
10-K
2022 FY
APTX
Aptinyx Inc.
Annual report
30 Mar 23
4:30pm
8-K
APTX
Aptinyx Inc.
30 Mar 23
Aptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic Alternatives
4:15pm
SC 13D/A
APTX
Aptinyx Inc.
16 Mar 23
Aptinyx / Longitude Capital Partners II ownership change
4:19pm
8-K
APTX
Aptinyx Inc.
1 Mar 23
Cost Associated with Exit or Disposal Activities
8:31am
8-K
APTX
Aptinyx Inc.
27 Feb 23
NYX-458 did not demonstrate sufficient efficacy in the Phase 2 study to support further development by Aptinyx
4:03pm
SC 13D/A
Longitude Capital Partners II, LLC
14 Feb 23
Aptinyx / Longitude Capital Partners II ownership change
4:31pm
SC 13G/A
APTX
Aptinyx Inc.
13 Feb 23
Aptinyx / Artal International S.C.A. ownership change
12:00am
SC 13G/A
APTX
Aptinyx Inc.
20 Jan 23
Aptinyx / Kryzanowski John A ownership change
10:42am
4
Ashish Khanna
5 Jan 23
Aptinyx / ASHISH KHANNA ownership change
4:17pm
4
APTX
Aptinyx Inc.
5 Jan 23
Aptinyx / NORBERT G RIEDEL ownership change
4:17pm
4
Andrew Kidd
5 Jan 23
Aptinyx / ANDREW KIDD ownership change
4:16pm
8-K
APTX
Aptinyx Inc.
8 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
APTX
Aptinyx Inc.
1 Dec 22
Departure of Directors or Certain Officers
4:06pm
10-Q
2022 Q3
APTX
Aptinyx Inc.
Quarterly report
8 Nov 22
4:30pm
8-K
APTX
Aptinyx Inc.
8 Nov 22
Aptinyx Reports Third Quarter 2022 Financial Results and Recent Highlights
4:15pm
8-K
APTX
Aptinyx Inc.
25 Aug 22
Aptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’s Disease and Dementia with Lewy Bodies
11:45am
8-K
APTX
Aptinyx Inc.
12 Aug 22
Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Fibromyalgia
7:15am
10-Q
2022 Q2
APTX
Aptinyx Inc.
Quarterly report
4 Aug 22
4:31pm
8-K
APTX
Aptinyx Inc.
4 Aug 22
Aptinyx Reports Second Quarter 2022 Financial Results and Recent Highlights
4:15pm
SC 13G/A
Kryzanowski John A
24 Jun 22
Aptinyx / Kryzanowski John A ownership change
2:33pm